With over 12 different types of human papilloma virus (HPV) that can cause cancer, it is the leading cause of cervical cancer in women. The HPV/Pap smear co-test has improved the accuracy of cervical cancer screening; however the test has several limitations. Recent advancements in molecular diagnostics have led to the development of genotype-specific HPV tests that accurately detect and differentiate HPV strains, including high-risk oncogenic types such as HPV-16 and HPV-18.

In this webinar you will:

• Learn about HPV type-specific testing

• Explore the recent trends in HPV diagnostics

• Discover urine-specific genotyping chemistry, which can provide a non-invasive, sensitive method for HPV detection

Speaker: Steven Hawkings, Ph.D.